Double maintains 1 strategies that include CRMD - CorMedix, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWC | 23.85% | $813.58M | 0.6% |
PRNT | 23.52% | $79.41M | 0.66% |
PBW | 23.43% | $263.42M | 0.65% |
IFRA | 23.32% | $2.51B | 0.3% |
IWMY | 22.81% | $109.69M | 1.02% |
BETZ | 22.69% | $75.81M | 0.75% |
ARTY | 22.33% | $984.47M | 0.47% |
XHE | 22.05% | $178.99M | 0.35% |
PTH | 22.03% | $104.10M | 0.6% |
IWO | 21.84% | $11.46B | 0.24% |
GSSC | 21.79% | $551.51M | 0.2% |
GRID | 21.78% | $2.41B | 0.56% |
SIL | 21.77% | $1.92B | 0.65% |
IWM | 21.55% | $62.41B | 0.19% |
NUKZ | 21.55% | $300.41M | 0.85% |
VTWO | 21.54% | $12.36B | 0.07% |
QQQJ | 21.41% | $614.21M | 0.15% |
PSC | 21.36% | $726.87M | 0.38% |
AIRR | 21.32% | $3.80B | 0.7% |
NUSC | 21.29% | $1.14B | 0.31% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UNF | 42.36% | $3.36B | +21.00% | 0.74% |
AORT | 30.29% | $1.24B | +23.20% | 0.00% |
FARO | 29.79% | $818.07M | +131.88% | 0.00% |
ASUR | 29.29% | $266.92M | +22.57% | 0.00% |
CDW | 28.35% | $23.14B | -22.34% | 1.43% |
SNX | 28.01% | $10.61B | -2.59% | 1.33% |
DLR | 27.90% | $59.22B | +17.55% | 2.75% |
PFGC | 27.82% | $13.53B | +25.65% | 0.00% |
GIC | 27.15% | $1.04B | -19.85% | 3.78% |
DNLI | 26.86% | $2.21B | -29.48% | 0.00% |
NSIT | 26.76% | $4.26B | -32.53% | 0.00% |
AVNS | 26.75% | $569.73M | -38.95% | 0.00% |
HRMY | 26.27% | $2.02B | +19.32% | 0.00% |
SIGA | 25.75% | $452.94M | -11.15% | 0.00% |
DHC | 25.16% | $813.02M | +15.02% | 1.17% |
ARCT | 24.95% | $337.38M | -59.95% | 0.00% |
IPI | 24.86% | $477.14M | +44.24% | 0.00% |
RRX | 24.68% | $9.54B | -1.13% | 0.99% |
UI | 24.67% | $24.25B | +173.56% | 0.60% |
GPRO | 24.57% | $135.54M | -45.55% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -16.44% | $153.01M | 0.85% |
TAIL | -15.54% | $107.77M | 0.59% |
BTAL | -14.31% | $298.87M | 1.43% |
SMMU | -12.63% | $861.62M | 0.35% |
XONE | -12.15% | $634.70M | 0.03% |
SHYD | -10.15% | $322.63M | 0.35% |
TBIL | -8.78% | $5.91B | 0.15% |
SUB | -7.68% | $9.69B | 0.07% |
SHM | -7.39% | $3.39B | 0.2% |
BILS | -7.37% | $3.93B | 0.1356% |
BSMW | -7.17% | $102.07M | 0.18% |
TFLO | -7.05% | $6.97B | 0.15% |
UTWO | -6.89% | $374.41M | 0.15% |
IBTG | -6.75% | $1.94B | 0.07% |
JMST | -6.70% | $3.84B | 0.18% |
MMIN | -6.50% | $479.55M | 0.3% |
GSST | -6.31% | $896.41M | 0.16% |
IBTO | -6.25% | $340.29M | 0.07% |
SGOV | -6.23% | $48.57B | 0.09% |
LDUR | -6.14% | $913.73M | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HTAB | 0.02% | $409.06M | 0.39% |
DFCF | -0.05% | $6.92B | 0.17% |
ILTB | -0.07% | $585.33M | 0.06% |
CANE | -0.07% | $10.08M | 0.29% |
FTSD | 0.13% | $228.13M | 0.25% |
IUSB | -0.17% | $32.23B | 0.06% |
QETH | 0.18% | $23.52M | 0.25% |
VCRB | -0.21% | $2.96B | 0.1% |
USTB | 0.21% | $1.24B | 0.35% |
IBDQ | 0.22% | $3.04B | 0.1% |
HYMB | 0.29% | $2.53B | 0.35% |
ETH | 0.33% | $1.27B | 0% |
GTO | 0.35% | $1.92B | 0.35% |
NUAG | -0.39% | $57.79M | 0.19% |
TIPX | 0.40% | $1.65B | 0.15% |
FETH | 0.44% | $1.14B | 0.25% |
BNDW | 0.46% | $1.24B | 0.05% |
LMBS | 0.48% | $5.03B | 0.64% |
MBB | -0.50% | $37.99B | 0.04% |
ETHV | 0.52% | $121.08M | 0% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COLD | <0.01% | $5.06B | -30.57% | 5.09% |
FENG | -0.01% | $11.12M | -22.26% | 0.00% |
SUPN | 0.02% | $1.86B | +22.42% | 0.00% |
CLX | 0.04% | $15.56B | -3.58% | 3.85% |
AMED | -0.06% | $3.18B | +5.52% | 0.00% |
EPC | 0.07% | $1.19B | -34.19% | 2.40% |
FLO | 0.07% | $3.45B | -27.85% | 5.98% |
UONEK | 0.07% | $28.54M | -61.18% | 0.00% |
V | -0.07% | $723.91B | +38.10% | 0.61% |
NEXA | 0.09% | $650.28M | -37.13% | 0.00% |
EVH | 0.09% | $1.01B | -62.74% | 0.00% |
CHTR | -0.10% | $55.22B | +45.35% | 0.00% |
TH | 0.11% | $692.57M | -8.53% | 0.00% |
PVH | -0.12% | $3.16B | -43.21% | 0.23% |
IRON | 0.13% | $1.76B | +30.91% | 0.00% |
BRFS | 0.14% | $6.10B | +12.54% | 0.00% |
HUM | 0.15% | $27.97B | -34.24% | 1.52% |
WRB | -0.15% | $27.46B | +41.55% | 0.49% |
QBTS | -0.17% | $5.13B | +1,325.00% | 0.00% |
CNK | -0.17% | $3.70B | +79.80% | 0.50% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
POAI | -19.42% | $8.93M | -25.97% | 0.00% |
OMCL | -17.22% | $1.42B | +4.68% | 0.00% |
JJSF | -16.16% | $2.24B | -31.27% | 2.67% |
KDP | -11.77% | $44.63B | -2.23% | 2.76% |
SEAT | -11.70% | $232.43M | -66.60% | 0.00% |
TCMD | -10.17% | $233.30M | -16.31% | 0.00% |
PRMB | -9.86% | $10.86B | +30.17% | 1.32% |
LPTH | -9.78% | $123.12M | +133.33% | 0.00% |
NOC | -9.78% | $70.30B | +14.35% | 1.72% |
PEP | -9.31% | $178.10B | -20.71% | 4.18% |
MO | -8.91% | $100.92B | +30.61% | 6.82% |
ABBV | -8.90% | $338.27B | +15.30% | 3.33% |
MNST | -8.28% | $61.04B | +25.76% | 0.00% |
BPT | -7.68% | $13.72M | -72.13% | 0.00% |
GRMN | -7.57% | $40.27B | +27.37% | 1.44% |
BRSP | -7.21% | $696.67M | -9.95% | 12.73% |
PULM | -7.07% | $30.39M | +340.19% | 0.00% |
PRAA | -6.95% | $600.04M | -25.91% | 0.00% |
NOMD | -6.83% | $2.67B | +1.69% | 3.66% |
MSIF | -6.76% | $831.23M | +47.01% | 6.11% |
Current Value
$14.451 Year Return
Current Value
$14.451 Year Return
SeekingAlpha
CorMedix (CRMD) is a buy with its financial turnaround, robust growth, and first-mover advantage in the US dialysis market. See more here.
SeekingAlpha
CorMedix's DefenCath drives 2025 stock success by cutting catheter infections. Strong Q1, no debt, and growth projections make it a must-watch stock. Read the full investment analysis here.
Yahoo
BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the Jefferies Global Healthcare Conference, taking place in New York on June 3 - 5, 2025. Jefferies Global Healthcare ConferenceDate:Thursday, June 5, 2025Time:3:45p.m. EDTFormat:PresentationWebcast:Link About CorMedix CorMedix Inc. is a biopharmaceut
Yahoo
BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC Capital Markets Global Healthcare Conference, taking place in New York on May 20-21, 2025. RBC Capital Markets Global Healthcare ConferenceDate:Wednesday, May 21, 2025Time:3:05p.m. EDTFormat:Fireside ChatWebcast:Link About CorMedixCorMedix Inc
Yahoo
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Galmed Pharmaceuticals (GLMD), 353% surge in interest Protagenic Therapeutics (PTIX), 345% surge in interest Hepion Pharmaceuticals (HEPA), 310% surge in interest Rigel Pharmaceuticals (RIGL), 290% surge in interest Bolt Biotherapeutics (BOLT), 274% surge in interest Palatin Technologies (PTN), 274% surge in interest Krystal Biotech (KRYS), 240% surge in
Yahoo
CorMedix Inc. ( NASDAQ:CRMD ) just released its first-quarter report and things are looking bullish. It was overall a...